Bio Essence (BIOE) Net Margin (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Net Margin of 41.03% in Q1 2026, down 41.01% quarter-over-quarter from 69.56% in Q4 2025, and up 96830.0% on a YoY basis from N/an in Q1 2025.
Bio Essence (BIOE) Net Margin (2020 - 2026) Analysis & Trends
Bio Essence's Net Margin history runs 7 years deep, the most recent figure standing at 41.03% for Q1 2026.
- In Q1 2026, Net Margin rose 96830.0% year-over-year to 41.03%; the TTM figure through Mar 2026 stood at 55.02% (up 14938.0% YoY), while the FY2025 annual figure was 47.23%, up 8453.0% from the prior year.
- Net Margin was 41.03% for Q1 2026 at Bio Essence, down from 69.56% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 245.51% in Q1 2024 to a low of 927.27% in Q1 2025.
- Historically, Net Margin has averaged 71.3% across 5 years, with a median of 41.03% in 2026.
- The sharpest annual moves came in 2025 and 2026: Net Margin tumbled 117278 bps in 2025, then jumped 96830 bps in 2026.
- A 5-year view of Net Margin shows it stood at 129.16% in 2022, then slumped by 136 bps to 304.3% in 2023, then jumped by 71 bps to 89.71% in 2024, then surged by 178 bps to 69.56% in 2025, then sank by 41 bps to 41.03% in 2026.
- The last three Net Margin figures came in at 41.03% (Q1 2026), 69.56% (Q4 2025), and 9.5% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | Bio Essence | - | - | 319,353.00 | 41.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.03% |
| Dec 31, 2025 | 69.56% |
| Sep 30, 2025 | 9.50% |
| Jun 30, 2025 | 23.10% |
| Mar 31, 2025 | -927.27% |
| Sep 30, 2024 | -89.71% |
| Mar 31, 2024 | 245.51% |
| Dec 31, 2023 | -304.30% |
| Sep 30, 2023 | -406.65% |
| Jun 30, 2023 | 109.61% |
| Mar 31, 2023 | 52.39% |
| Dec 31, 2022 | -129.16% |
| Sep 30, 2022 | 103.74% |
| Jun 30, 2022 | 56.98% |
| Mar 31, 2022 | 76.08% |
| Dec 31, 2021 | 42.54% |
| Sep 30, 2021 | 80.64% |
| Jun 30, 2021 | 69.32% |
| Mar 31, 2021 | -99.21% |
| Dec 31, 2020 | -40.90% |